Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to UPM’s webcast and press conference on Q3 2023 Interim report

(UPM, Helsinki, 17 October 2023 at 10:00 EEST) – UPM will publish its Q3 2023 results on Tuesday, 24 October 2023 at 09:30–10:00 EEST. After publishing, the report will be available on the company website at www.upm.com . A webcast and a conference call for analysts and investors in English begins at 13:15 EEST. The interim report will be presented by the President and CEO Jussi Pesonen and CFO Tapio Korpeinen. Participants can view the webcast online through this link , but those who wish to ask questions from the

Diamyd Medical announces a webcast presentation on October 20 regarding its industry partnership with JDRF

Diamyd Medical is hosting a webcast presentation on October 20th at 2:00 pm CET / 8:00 am EDT with Ulf Hannelius, CEO of Diamyd Medical, Josh Vieth, Director of Research at JDRF, as well as Mark Atkinson, Director for the University of Florida Diabetes Institute and member of the Board of Directors of Diamyd Medical. The webcast will review the industry partnership between Diamyd Medical and JDRF announced in April of this year, discuss the current state of immunomodulatory approaches in Type 1 Diabetes and most notatably, the antigen-specific immunotherapy Diamyd[®] that is currently

Moberg Pharma’s Nomination Committee appointed

STOCKHOLM, October 17[th], 2023 – In accordance with the resolution of the Annual General Meeting on May 16[th], 2023, the Chairman of the Board has contacted the company’s two largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company’s two largest shareholders or group of shareholders have wished to appoint such representative, the third largest shareholder/group of

Invitation to web presentation of Formpipe’s Q3 report 2023.

Formpipe will publish its interim report for the third quarter 2023 on Wednesday 25 October 2023 at 08:15 (CEST).The same day at 10:00 (CEST), Formpipe’s President and CEO Magnus Svenningson will host a web presentation in English which is webcasted live on: http://www.formpipe.com/en/q32023, where it also will be available on demand shortly afterwards. Following the presentation, Magnus Svenningson, and Joakim Alfredson CFO, will be available to answer questions. The report and presentation will be available at: www.formpipe.com/en/investors/reports-and-presentations Welcome!

Wyld Networks fulfils obligations to European Space Agency (ESA) to develop satellite-to-satellite connectivity with Eutelsat and Thales

Wyld Networks have delivered the LoRaWAN satellite-to-satellite connectivity solution as part of a joint ESA-sponsored programme with Eutelsat and Thales for telemetry and control to support satellite IoT networks. Wyld have used LoRa CSS and LoRa FHSS protocols to establish bi-directional communication with satellites and ground stations. As part of the program, Wyld’s IoT module is being built into low earth orbiting satellites to provide radio connectivity. Wyld have now delivered this technology to the programme. Satellite-to-satellite connectivity will not only improve command

Members of the Nomination Committee for Episurf Medical’s Annual General Meeting in 2024

In accordance with the decision by the Annual General Meeting, Episurf Medical’s Nomination Committee shall consist of four members. The members are selected by the three largest shareholders in the company that wish to participate in the committee. In addition, the Chairman of the Board is to be appointed to the Nomination Committee. The members of the Nomination Committee shall agree on a chairman/woman of the committee. In accordance with the above principles, the Nomination Committee consists of the following four members: · Ulf Grunander, styrelseordförande i Episurf Medical AB

HANZA presents interim report November 7

HANZA will publish its interim report for the third quarter of 2023 on November 7 at 8.00 am CET. In connection with the report, HANZA invites investors, analysts and media to a combined conference call and audiocast at 11.00 am CET the same day.The report will be presented by CEO Erik Stenfors and CFO Lars Åkerblom. The presentation will be held in English. Time: Tuesday, November 7 at 11:00 a.m. Participate via webcast: https://financialhearings.com/event/46046 Participate via teleconference: Register via this link to 

Catena Media announces share buybacks executed from 9 to 13 October 2023

Catena Media plc (LEI code: 549300609A73DL5C5Z86) repurchased 75,000 of its own ordinary shares (ISIN code: MT0001000109) from 9 to 13 October 2023 as part of its share buyback programme. The buyback programme was authorised by shareholders at an extraordinary general meeting on 12 July 2023 and initiated and announced by the board of directors on 17 July 2023. The programme is being carried out in accordance with the EU Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) 2016/1052 (the "Safe Harbour Regulation"). Its purpose is to deliver

Ratos Company Semcon spins off its Product Information business area, introduces Aleido

Semcon announces the successful spinoff of its Product Information business area, marking the official launch of new and stand-alone company Aleido. This strategic step has been taken to strengthen both businesses and to continue growing their offers, dedicated teams, and profitability.The Product Information business area, with its 850 employees in five countries, is known for its expertise in creating user-friendly digital aftermarket solutions for complex products. As a global leader, it serves customers such as Volvo Cars, Tetra Pak, Alstom, AGCO, Jaguar Land Rover and Epiroc.“At

Eevia Health Plc received a 168 kSEK / 15 kEUR order for a rapeseed extract.

Eevia Health Plc, (”Eevia” or ”The Company”), has received a sales order from a Finnish food company for a custom made rapeseed extract for the value of 15 kEUR (168 kSEK).The customer is a large food ingredient manufacturer, and a significant producer of vegetable and rapeseed oils. Their main markets for are Finland and the other Nordic countries. Eevia will fulfill this order by extracting a custom-made rapeseed extract based. The order is based an exclusive frame agreement for this product. The order is expected to create repeat sales of this product going forward. For further

INVITATION: Finnair Q3 2023 result – Press conference / webcast and analyst webcast

Finnair will hold a Q3 2023 results press conference (in Finnish) on 24 October 2023 at 12.00 p.m. EEST at its office at Tietotie 9, Vantaa. It is also possible to participate in the press conference via a live webcast at https://finnairgroup.videosync.fi/2023-10-24-press.    An English-language telephone conference and webcast will be held on 24 October 2023 at 3.00 p.m. EEST. To access the conference, kindly first register at https://palvelu.flik.fi/teleconference/?id=10010297. After the registration, you will be provided with phone numbers and a conference ID. We kindly suggest

Invitation to conference call with web presentation of Cloetta AB´s interim report Q3 2023

Cloetta AB will publish the interim report for the period 1 July – 30 September 2023 on Friday 27 October 2023 at 7.30 a.m. CEST. Following this report Cloetta will organise a conference call with web presentation for media and the financial community.President and CEO Henri de Sauvage Nolting and CFO Frans Rydén will present and comment on the report. After the presentation there will be time for questions, both on the phone and in the web presentation.   Time for the publication of the interim report Friday 27 October at 07:30 a.m. CEST    Time for conference call and web

Peab builds wastewater treatment plant in Ålesund

Peab has been commissioned to build Fremmerholen’s new wastewater treatment plant in Ålesund. The customer is Ålesund Municipality and the contract is worth NOK 202 million.Ålesund Municipality’s existing wastewater treatment plant delivers clean water to around 70,000 inhabitants. The new wastewater treatment plant will be vital in ensuring the supply of clean water to Ålesund and surrounding communities. The project includes building a processing plant, a wastewater cleaning plant and a two story pump station. Peab will also be responsible for the groundwork and plumbing installations.

Swedish healthcare company teams up with Dutch artist to co-create art of hospital waste

· Artist Maria Koijck challenged the healthcare industry with art project based on waste from own breast cancer surgery · Mölnlycke Health Care responded by showing that up to 90%[1] of packaging waste can be saved by switching to surgical traysGothenburg, 17 October 2023: At the height of a global discussion around the need to reduce hospital waste, an innovative partnership between a Dutch artist and a Swedish healthcare company shows that up to 90% of packaging waste, the major contributor to operating room waste, can be reduced. In 2019 Dutch artist Maria Koijck underwent a full

Repurchases of shares by Concentric AB during week 41, 2023

Between 9 October 2023 and 13 October 2023 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 19,705 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares for a total maximum amount of SEK 150,000,000 that Concentric announced on 26 July 2023. The repurchase program, which runs between 31 July 2023 and 31 March 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

Powerbox’s COTS/MOTS 1200W power supplies ideal for defense and harsh environments

Powerbox , one of Europe’s largest power supply companies and a leading force for four decades in optimizing power solutions for demanding applications, has announced the release of its new ruggedized 1200W AC/DC power supply for ground based defense applications and harsh industrial environments. In metal chassis format with a baseplate for conduction cooling, the OFD1200A series  can be used with a baseplate operating temperature range of -40 up to +95 degrees C. For extremely demanding applications the OFD1200A features a

Zinnwald Lithium and Metso advance joint testwork program

Metso Corporation’s press release on October 17, 2023, at 09:00 a.m. EESTZinnwald Lithium Plc (“Zinnwald Lithium”) and Metso continue to make excellent progress developing the beneficiation plant concept for the integrated Zinnwald Lithium Project located near Dresden, Germany. This unique project, which is situated in the heart of the European chemical and automotive industries, is designed to supply battery-grade lithium hydroxide (LiOH) to the battery sector. Anton du Plessis, CEO of Zinnwald Lithium, comments: “Achieving resilience and sustainability for the electric vehicle battery

Orkla ASA – Invitation to Capital Markets Day, 29 November 2023

Orkla – Capital Markets DayWednesday 29 November 2023etc.venues St Paul's, 200 Aldersgate, London EC1A 4HD12.00 UTC / 13.00 CETOrkla is pleased to invite investors, analysts and financial media to our Capital Markets Day in London on Wednesday 29 November 2023. The event will start at 12.00 UTC (registration and lunch from 11.00 UTC) and is expected to last until 16:00 UTC (approximately). The programme will cover a strategic and financial update on the Group, as well as presentations of the plans and ambitions for six of Orkla’s twelve portfolio companies. Speakers:Nils K.

Carsten Henke appointed as Managing Director of Tietoevry Industry

Tietoevry Corporation     STOCK EXCHANGE RELEASE     17 October 2023 9:00 a.m. EEST Tietoevry Industry is one of Tietoevry’s five businesses which specializes in industry-specific software, and data platform services. Tietoevry Industry’s over 1 600 experts are digitalizing business-critical processes for enterprises and public sector, ensuring business continuity and modernization in segments such as Public sector, Education, Pulp, Paper & Fibre, and Energy & Utilities. Effective 1 November 2023, Carsten Henke is appointed as the Managing Director of Tietoevry Industry. Carsten Henke

Invitation to presentation of Balder’s Interim report January-September 2023

On 27 October at 08:00 (CET), Fastighets AB Balder will be publishing its Interim report for January to September 2023. The report will be published at balder.se . On the same day at 08:45, Balder’s CEO Erik Selin and CFO Ewa Wassberg will be holding an online presentation and telephone conference that analysts, investors, media and other stakeholders are welcome to attend. The presentation will be held in English, and during the telephone conference there will be an opportunity for representatives from the financial market to

Olvi Group’s Interim Report January–September 2023

OLVI PLC                             Interim report 17 October 2023 at 9 am Olvi Group’s interim report January–September 2023 Sales volume decreased as a result of unfavourable weather in late summer – measures to improve profitability continue July–September 2023 · Net sales decreased by 2.2% and were EUR 171.1 (174.9) million. Unfavourable weather in late summer decreased the sales volume by 5.4% · The operating result was EUR 20.5 (25.0) million. · The relative gross profit remained at the same level as in the second quarter. However, it decreased year-on-year

Record high lettings volume in our investment properties

· Rental income increased to SEK 1,064 million (921) · Income from property management amounted to SEK 446 million (528) · Unrealised changes in the value of properties amounted to SEK -1,123 million (2,792) · The company posted a loss for the period of SEK 611 million (3,372) · Value of property portfolio increased to SEK 28,350 million (26,994) · Earnings per share amounted to SEK -5.1 (28.14) · Johanna Hult Rentsch took over as CEO on 14 August · Net lettings in the quarter amounted to SEK 8 million · Operating surplus increased to SEK 276 million · Lease signed

Lytix Biopharma granted up to NOK14.3m (US$1.3m) of public non-dilutive funding from ’SkatteFUNN’

Oslo, 17 October 2023. Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a clinical stage immuno-oncology company, announces that the Research Council of Norway has approved Lytix’s application for up to NOK14.3m (US$1.3m) of non-dilutive financial support from the  ‘SkatteFUNN’ R&D tax incentive scheme for a project in respect of Lytix's lead program: ‘Intratumoral LTX-315 in advanced melanoma’.The approval gives Lytix the right to claim tax deductions for relevant and documentable costs related to research and development activities in the approved project for

Lantmännen updates its dividend policy towards its members

Lantmännen updates its dividend policy towards its members. The change enables a larger share of the profit after tax from the industrial operations to be distributed. The policy forms a framework for the Lantmännen’s Board of Directors to refer to when they make proposals regarding dividends to the Annual General Meeting.The aim for Lantmännen is to generate an even and stable dividend over time to its members, active Swedish farmers. The decision means that the dividend can be up to 50 percent of the profit after tax from the industrial operations within Lantmännen, previously this

There are no items matching the current filter
There are no more items matching the current filter
Back to top